PA VOLBERDING, DI ABRAMS, M CONANT … - Annals of internal …, 1985 - Am Coll Physicians Single-agent intravenous vinblastine, 4 to 8 mg/week, was used to treat 38 patients with Kaposi's
sarcoma related to the acquired immunodeficiency syndrome. The dose was titrated in relation to the
total leukocyte count. Ten patients ... Cited by 117 - Related articles - All 3 versions
- ►jcojournal.org [PDF] LJ Laubenstein, RL Krigel, CM Odajnyk, KB … - Journal of Clinical …, 1984 - jcojournal.org UNTIL RECENTLY, disseminated, lymph- adenopathic Kaposi's sarcoma (KS) was an unusual tumor in North
America and results from systemic treatment were seldom reported. Clini- cal experience in West
Africa had described it as a ... Cited by 131 - Related articles - All 5 versions
DM MINTZER, FX REAL, L JOVINO, SE … - Annals of internal …, 1985 - Am Coll Physicians Kaposi's sarcoma occurs in about one third of patients with the acquired immunodeficiency syndrome.
Although in some patients the tumor is principally a cosmetic problem, other patients have
progressive disease with ... Cited by 104 - Related articles - All 3 versions
L Kaplan, D Abrams, P Volberding - Cancer treatment reports, 1986 - ncbi.nlm.nih.gov Twenty-four patients with acquired immunodeficiency syndrome and Kaposi's sarcoma (KS) were treated
with a regimen alternating vincristine with vinblastine on a weekly basis. Objective responses to
this regimen were observed in nine ... Cited by 71 - Related articles - All 2 versions
PS Gill, M Rarick, JA McCutchan, L Slater, B Parker, … - The American journal of …, 1991 - Elsevier Complete and partial tumor remissions were significantly higher with ABV (88%) than with Adriamycin
alone (48%) (p = 0.004). The median survival was 9 months in both groups. Study entry criteria
significantly associated with ... Cited by 149 - Related articles - All 6 versions
K Lassoued, JP Clauvel, C Katlama, M Janier, … - CA A Cancer Journal … - interscience.wiley.com A nonrandomized trial was conducted to assess the efficiency and toxicity of bleomycin as a
single agent in treatment of non-life-threatening AIDS-related Kaposi's sarcoma (KS). Sixty patients
were enrolled in this study. They all had a disseminated and progressive non-life- ... Cited by 45 - Related articles - All 2 versions
EP Gelmann, D Longo, H Clifford Lane, AS Fauci, H … - The American journal of …, 1987 - Elsevier Two clinical trials were conducted to assess the efficacy and safety of a combination chemotherapy
regimen for the treatment of Kaposi's sarcoma in patients with the acquired immune deficiency
syndrome (AIDS). Eighteen ... Cited by 58 - Related articles - All 5 versions
P Gill, M Rarick, M Bernstein-Singer, M Harb, … - American Journal of …, 1990 - journals.lww.com Am J Clin Oncol (CCT) 13(4): 315-319, 1990. 1990 Raven Press, Ltd., New York Treatment of Advanced
Kaposi's Sarcoma Using a Combination of Bleomycin and Vincristine Parkash Gill, MD, Mark Rarick, MD,
Marjorie Bernstein-Singer, md, ... Cited by 68 - Related articles - All 3 versions
MA Fischl, SE Krown, KP O'Boyle, R … - JAIDS Journal of …, 1993 - journals.lww.com Fifty-three patients with AIDS-related Kaposi's sarcoma and no previous treatment with
cytotoxic chemotherapy enrolled in a phase II multicenter study to evaluate the safety and efficacy
of weekly doxorubicin treatment. ... Cited by 38 - Related articles - BL Direct - All 4 versions
- ►jcojournal.org [PDF] SC Remick, M Reddy, D Herman, C Grace, G … - Journal of Clinical …, 1994 - jcojournal.org Purpose: To determine the toxicity, response, and survival rate of 72-hour continuous infusion
bleomycin administered to patients with AIDS-related Kaposi's sar- coma. Patients and Methods:
Seventeen patients with bi- ... Cited by 23 - Related articles - All 6 versions
